arrow
L

Lilian T. Gien

University of Toronto
H指数:28
被引数:3,671

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A randomized, phase III study of sacituzumab govitecan versus treatment of physician’s choice in patients with endometrial cancer after platinum-based chemotherapy and immunotherapy: the ASCENT-GYN-01 study (GOG-3104/ENGOT-en26/APGOT-EN2)

一项关于sacituzumab govitecan与医生选择治疗方案在经过铂类化疗和免疫治疗后的子宫内膜癌患者中的随机、III期研究:ASCENT-GYN-01研究(GOG-3104/ENGOT-en26/APGOT-EN2)。

2025-09-070
PRE
Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical Cancer
2024-08-010
PRE
Updated response data and analysis of progression free survival by mechanism of mismatch repair loss in endometrial cancer (EC) patients (pts) treated with pembrolizumab plus carboplatin/ paclitaxel (CP) as compared to CP plus placebo (PBO) in the NRG GY018 trial
2023-10-017
PRE
Pembrolizumab Plus Chemotherapy in Advanced Endometrial Cancer
2023-07-011
PRE
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
2023-06-08246
OA
Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging
2021-02-01155
OAAI